PEGS China

About PEGS

CHI is excited to announce the launch of “PEGS China”. Spurred by the growth in the biopharmaceutical sector in Asia and the demand by our participants and exhibitors to bring higher quality, established and credible conferences to this region, CHI will launch its first Asia PEGS Summit in China in April 2014. The event will focus on topics of greater relevance and interest to the China/Asia biopharmaceutical industry, including protein and antibody engineering, protein expression, analytical techniques and CMC strategies.

“PEGS Summit” has grown in leaps and bounds driven by the growth in biologics worldwide. Attracting over 1600 participants at this year’s 9th Annual PEGS Summit in Boston, and record attendance expected at the upcoming PEGS Europe event being held in Lisbon, “PEGS” is CHI’s flagship biologics event, and considered the industry leading event.

AUDIENCE PROFILE

Scientists, engineers and executives working in

• protein/antibody engineering
• protein/antibody expression
• cell line engineering
• ADCs and bispecifics
• biosimilars development
• immunogenicity
• formulation
• analytical chemistry
• analytical method development
• up- and down-stream processing
• technical services
• manufacturing sciences and technology
• facilities design and technologies